We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA's Initiatives Sufficient to Improve Postmarket Reviews
FDA's Initiatives Sufficient to Improve Postmarket Reviews
May 19, 2006
The FDA believes that its ongoing efforts to improve postmarket drug reviews are sufficient to address perceived flaws in the agency’s drug review procedures, a key agency official says.